LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report

Photo from wikipedia

Heparin-induced thrombocytopenia (HIT) is a potentially lifethreatening prothrombotic complication that affects 0,5−3% of patients exposed to unfractionated heparin (UFH).1,2 HIT occurs due to antibodies produced against platelet factor 4 (PF4)… Click to show full abstract

Heparin-induced thrombocytopenia (HIT) is a potentially lifethreatening prothrombotic complication that affects 0,5−3% of patients exposed to unfractionated heparin (UFH).1,2 HIT occurs due to antibodies produced against platelet factor 4 (PF4) and heparin complex. Those antibodies may cause intravascular platelet consumption and increased thrombin generation, resulting in thrombocytopenia and thromboembolic phenomena, which are the main clinical features of HIT.1 Evaluation of suspected HIT involves the application of probability score systems: 4 T score3 or HEP score.4 Patients with intermediate or high HIT probability, should undergo additional laboratory tests. The anti-PF4-heparin enzyme immunoassays are very useful due to their very high negative predictive value. Additionally, functional assays with washed platelets may help in some cases.

Keywords: heparin induced; heparin; induced thrombocytopenia; fondaparinux systemic; systemic anticoagulation; anticoagulation continuous

Journal Title: Hematology, Transfusion and Cell Therapy
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.